- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The term "cryotherapy" refers to a procedure when the body is exposed to extremely low temperatures for a number of minutes. A process whereby abnormal tissue is frozen and destroyed using a cryoprobe or an extremely cold liquid.
Liquid nitrogen, liquid nitrous oxide, or compressed argon gas are used to chill cryoprobes. There is a device for some cancers and disorders that could develop into cancer may be treated with cryotherapy.
The cryotherapy device helps cure mental illnesses, reduces the symptoms of migraine, treats additional skin problems in addition to atopic dermatitis, could be used to treat low-risk cancers, numbs irritated nerves, and could aid in the prevention of dementia and Alzheimer's disease.
Cryotherapy became more popular in the beauty and aesthetics industries. In addition, it is being embraced as a new style by athletes and celebrities.
The global Cryotherapy device market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Through a recently established cooperation with America Cryo, The Spa Butler has made the Subzero accessible to interested parties in all pertinent industries and businesses.
The CoolRestore cryotherapy equipment from Zemits has been released into the marketplace. Cryo mode and smart mode are the device's two therapy modes.
Cryotherapy can be used in one target area for anywhere between 15 and 30 minutes in the cryo treatment mode, which uses cold therapy as low as -18 °C.
The smart treatment mode offers a pre-programmed routine that alternates between two minutes of hot and cold therapy.
The Spa Butler, a prominent figure in the thriving cryotherapy market, is launching yet another ground-breaking item for the community of health-conscious people: Cryotherapy facials are simple, affordable, and accessible thanks to the Subzero by America Cryo, a localised cosmetic skin cooling device that achieves sub-zero temperatures.
Both sports therapists and aestheticians are praising the Subzero local cryotherapy machine for its remarkable advantages for clients, including injury recovery, support for physical therapy, wrinkle reduction, removal of sun spots, collagen boosting, reduction of inflammation and swelling, and increased blood flow.
Since the CO2 device does not require nitrogen to operate, there is no risk of suffocation from breathing nitrogen fumes or burning from moving liquid nitrogen between cryogenic dewars.
A new CO2-based cryotherapy equipment has been introduced by women's health organization Pregna International to aid in the fight against cervical cancer.
With prompt secondary and tertiary level screening and treatment, a significant portion of fatalities can be avoided. Healthcare professionals at all levels will be able to properly treat the disease thanks to CryoPop.
The FDA has approved the next-generation Cerene cryotherapy device from Channel Medsystems, Inc., a medical device business whose aim is to empower every woman to take charge of her health journey. The gadget is used to treat menstrual bleeding.
With Cerene, an in-office endometrial cryoablation procedure, heavy monthly bleeding is safely and successfully reduced, and discomfort is naturally reduced without the need for general anesthesia.
Denta-Cool has introduced its product on the North American market, a cutting-edge cryotherapy technology created to efficiently relieve oral discomfort and swelling for dental patients.
Denta-Cool is an intraoral mouthpiece with therapeutic design that interacts with the entire oral cavity to deliver cooling and lessen discomfort for dental patients experiencing pain and swelling following dental surgery.
For the purpose of launching and marketing its cryotherapy device known as Chemo Mouthpiece for oncology patients in the US, ChemoMouthpiece has partnered with supplier of commercialization services EVERSANA.
The Chemo Mouthpiece device is an intraoral ice pack that is intended to deliver cryotherapy to a patient receiving chemotherapy in the oral cavity.
The US-based startup created the cryotherapy equipment to preventatively control and treat oral mucositis, a side effect of chemotherapy.
In accordance with the conditions of the cooperation, EVERSANA will provide a range of commercialization services to assist with the introduction of the device in the US.
It will offer services for market access strategy, patient services, field deployment solutions, data and analytics, pricing strategy, and 3PL distribution for the device in addition to compliance and regulatory services.
They need a partner who has experience not only in commercialization but also in-depth knowledge of the oncology field in order to continue to strive to bring the Chemo Mouthpiece to market.
Commercialising medical equipment, especially for cancer, is exceedingly hard. EVERSANA meets this description, but what makes them stand out and makes them the ideal partner for us is their dedication to patient-centred care and unrivalled drive to build a better world.
In order to decrease the frequency and severity of oral mucositis, the US Food and Drug Administration (FDA) recently designated the Chemo Mouthpiece device as a breakthrough device.
Patients are said to be able to continue their treatment with less disruption and more comfort thanks to the cryotherapy equipment, which is marketed as being straightforward, efficient, and simple to use.
While receiving chemotherapy at home or in a hospital, it cools the entire oral cavity. According to EVERSANA, patients can take the gadget with them for treatment and freeze it at home, providing a brand-new answer to a previously unmet patient demand.
The creation of temperature-negative expansion nanodrugs is a potential route that scientists are hoping will lead to effective cancer treatments in the near future, making cryotherapy devices a crucial component of nanotechnology.
The resolution of biomolecular structures has risen to almost atomic levels thanks to developments in software algorithms and sensing technology.
This has aided in the study of previously complex viruses and bacteria in medicine. These improvements in bioengineering technology have greatly helped cryogenic-electron microscopy.
In order to assess samples' macromolecular structures without crystallisation, this method entails freezing the materials to cryogenic temperatures.
The existing partnership between bioengineering and cryotherapy in the field of medical research has the potential to cut the current several days needed for sample inspection in half to as little as an hour.
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in theIndustry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.